Sunday, November 8, 2026

GBP/EUR Bearish Momentum: 0.85% Down In The Last 5 Sessions

GBP/EUR Bearish Momentum: 0.85% Down In The Last 5 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 0.85% for the last 5 sessions. At 23:10 EST on Thursday, 22 June, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 7.5% up from its 52-week low and 3.044% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a positive 0.06%, and a positive 0.23%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.29% (last week), 0.25% (last month), and 0.23% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy bounces off 100-hour sma, trades with a mild positive bias above mid-141.00s. According to FXStreet on Wednesday, 21 June, "The Japanese Yen (JPY) continues to be undermined by a more dovish stance adopted by the Bank of Japan (BoJ), which, in turn, acts as a tailwind for the USD/JPY pair. ", "This, in turn, should help investors to determine the near-term trajectory for the USD/JPY pair. "
  • Usd/jpy remains on the defensive below 142.00 mark, downside seems limited. According to FXStreet on Thursday, 22 June, "This marks a big divergence in comparison to the Fed projections for a higher peak interest rate this year and suggests that the path of least resistance for the USD/JPY pair is to the upside. ", "The US Dollar (USD) consolidates the overnight slide back closer to the monthly low in the wake of Federal Reserve (Fed) Chair Jerome Powell's less hawkish remarks and turns out to be a key factor acting as a headwind for the USD/JPY pair. "
  • Usd/jpy: 200-dma near 138/137.20 expected to provide support – socgen. According to FXStreet on Wednesday, 21 June, "Economists at Société Générale analyze USD/JPY technical outlook."
  • According to FXStreet on Wednesday, 21 June, "At the time of writing, USD/JPY is trading close to the intraday high of 141.86, up 0.22% on the day."
  • Usd/jpy price analysis: extends bounce off 141.40 support confluence within rising wedge. According to FXStreet on Wednesday, 21 June, "It's worth observing that the bullish MACD signals and the firmer RSI (14) line, not overbought, add strength to the upside bias about the USD/JPY pair.", "On the flip side, a downside break of the 141.40 support confluence isn't an open welcome for the USD/JPY bears as the 200-HMA and a fortnight-long rising trend line, close to 140.50 and 139.80 in that order, could check the sellers."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com